Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon Collins

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Genes|November 27, 2021
ChromeBat: A Bio-Inspired Approach to 3D Genome ReconstructionBrandon Collins, Oluwatosin Oluwadare, Philip Brown
Radiology Case Reports|August 22, 2025
A case of anti-N-methyl-D-aspartate receptor encephalitis with associated ovarian teratoma in a 23-year-old femaleAlexandra Hodder, Brandon Collins, Joseph Yang, et al.
Science (New York, N.Y.)|November 21, 2015
Wildfires--ResponseMalcolm North, Scott Stephens, Brandon Collins, et al.
Journal of Medicinal Chemistry|May 11, 2013
Discovery of potent, selective chymase inhibitors via fragment linking strategiesSteven J Taylor, Anil K Padyana, Asitha Abeywardane, et al.
Journal of Medicinal Chemistry|July 28, 2015
Correction to Fragment-Based Discovery of Indole Inhibitors of Matrix Metalloproteinase-13Steven J Taylor, Asitha Abeywardane, Shuang Liang, et al.
Journal of Medicinal Chemistry|October 25, 2011
Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13Steven J Taylor, Asitha Abeywardane, Shuang Liang, et al.
ACS Omega|August 2, 2021
Indole Inhibitors of MMP-13 for Arthritic DisordersSteven J Taylor, Asitha Abeywardane, Shuang Liang, et al.
Journal of Medicinal Chemistry|December 15, 2015
Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of OsteoarthritisPeter G Ruminski, Mark Massa, Joseph Strohbach, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritisMark E Schnute, Patrick M O'Brien, Joe Nahra, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Genes|November 27, 2021
ChromeBat: A Bio-Inspired Approach to 3D Genome ReconstructionBrandon Collins, Oluwatosin Oluwadare, Philip Brown
Radiology Case Reports|August 22, 2025
A case of anti-N-methyl-D-aspartate receptor encephalitis with associated ovarian teratoma in a 23-year-old femaleAlexandra Hodder, Brandon Collins, Joseph Yang, et al.
Science (New York, N.Y.)|November 21, 2015
Wildfires--ResponseMalcolm North, Scott Stephens, Brandon Collins, et al.
Journal of Medicinal Chemistry|May 11, 2013
Discovery of potent, selective chymase inhibitors via fragment linking strategiesSteven J Taylor, Anil K Padyana, Asitha Abeywardane, et al.
Journal of Medicinal Chemistry|July 28, 2015
Correction to Fragment-Based Discovery of Indole Inhibitors of Matrix Metalloproteinase-13Steven J Taylor, Asitha Abeywardane, Shuang Liang, et al.
Journal of Medicinal Chemistry|October 25, 2011
Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13Steven J Taylor, Asitha Abeywardane, Shuang Liang, et al.
ACS Omega|August 2, 2021
Indole Inhibitors of MMP-13 for Arthritic DisordersSteven J Taylor, Asitha Abeywardane, Shuang Liang, et al.
Journal of Medicinal Chemistry|December 15, 2015
Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of OsteoarthritisPeter G Ruminski, Mark Massa, Joseph Strohbach, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritisMark E Schnute, Patrick M O'Brien, Joe Nahra, et al.
Pageof 1